Revolver Therapeutics

Transcription block survival for cancer therapies
 

Revolver creates structured, cell-permeable peptide drug leads inside living cells. Using small, functional crosslinkers, they stabilize peptides to selectively target oncogenic transcription factors, overcoming key limitations in peptide drug discovery and unlocking new therapeutic possibilities in cancer treatment.

 
https://www.bath.ac.uk/corporate-information/spin-out-companies-from-university-of-bath-research/

 

 

2025 finalists

Take a look at the finalists across the four competition categories